Correlation Between Fidelity MSCI and IShares Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fidelity MSCI and IShares Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity MSCI and IShares Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fidelity MSCI Industrials and iShares Genomics Immunology, you can compare the effects of market volatilities on Fidelity MSCI and IShares Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity MSCI with a short position of IShares Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity MSCI and IShares Genomics.

Diversification Opportunities for Fidelity MSCI and IShares Genomics

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Fidelity and IShares is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity MSCI Industrials and iShares Genomics Immunology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Genomics Imm and Fidelity MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity MSCI Industrials are associated (or correlated) with IShares Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Genomics Imm has no effect on the direction of Fidelity MSCI i.e., Fidelity MSCI and IShares Genomics go up and down completely randomly.

Pair Corralation between Fidelity MSCI and IShares Genomics

Given the investment horizon of 90 days Fidelity MSCI Industrials is expected to generate 0.78 times more return on investment than IShares Genomics. However, Fidelity MSCI Industrials is 1.29 times less risky than IShares Genomics. It trades about 0.33 of its potential returns per unit of risk. iShares Genomics Immunology is currently generating about 0.08 per unit of risk. If you would invest  7,142  in Fidelity MSCI Industrials on September 1, 2024 and sell it today you would earn a total of  597.00  from holding Fidelity MSCI Industrials or generate 8.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fidelity MSCI Industrials  vs.  iShares Genomics Immunology

 Performance 
       Timeline  
Fidelity MSCI Industrials 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity MSCI Industrials are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, Fidelity MSCI unveiled solid returns over the last few months and may actually be approaching a breakup point.
iShares Genomics Imm 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Genomics Immunology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, IShares Genomics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Fidelity MSCI and IShares Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fidelity MSCI and IShares Genomics

The main advantage of trading using opposite Fidelity MSCI and IShares Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity MSCI position performs unexpectedly, IShares Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Genomics will offset losses from the drop in IShares Genomics' long position.
The idea behind Fidelity MSCI Industrials and iShares Genomics Immunology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities